The purpose of this Institutional Biosafety Committee (IBC) policy is to define the institutional process for reporting exposures, injuries, releases or other incidents involving biological materials.
Principal investigators (PIs) are responsible for ensuring fulfillment of reporting requirements specified in their approved biosafety protocol. Exposures, potential exposures, injuries, releases, or other incidents involving biological materials must be reported using the First Report of Biological Exposure or Release Event form or other approved reporting mechanism. Reporting should be done as soon as possible but must be completed within 24 hours of the incident unless a different timeline is specified in the biosafety protocol.
The Biological Safety Officer (BSO) or designee will determine whether the incident should be reported to the NIH/OSP and in what timeframe according to the NIH Guidelines. If the incident involves recombinant materials, including recombinant or synthetic nucleic acids, recombinant microbes, transgenic animals, or transgenic plants, the BSO or designee will fulfill this reporting obligation as required by the NIH Guidelines. Reportable incidents may include injuries, spills, exposures or potential exposures, and violations of the NIH Guidelines. All incidents that are reported to the NIH/OSP will also be reported to the IBC at the next convened meeting. In cases where incidents are reported to the NIH/OSP in an expedited fashion and the next convened IBC meeting does not occur within that timeframe, the IBC Chair will be notified.
IBC-OBS Guidance Incident Reporting, internal document